Tim Cross
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Liver Disease and Transplantation 5
- Liver Diseases and Immunity 2
-
- Liver Disease Diagnosis and Treatment 11
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- COVID-19 and healthcare impacts 1
-
- Clinical practice guidelines implementation 1
-
- Cardiac, Anesthesia and Surgical Outcomes 1
- Co-authors
- Dinesh JothimaniMark EllulMatthew CrampIan RoweAnya BurtonR. DriverDaniel H. PalmerU. Warshow
- Cited by
- HepatologyEpidemiologySurgery
- Journals
- British Journal of Cancer (2 papers)European Journal of Surgical Oncology (2 papers)BMJ Open (1 paper)
- Partner nations
- United KingdomIndia
In The Last Decade
Tim Cross
20 papers receiving 265 citations
Peers
Comparison fields: 5 of 57
- Hepatology 154
- Epidemiology 137
- Surgery 112
- Oncology 56
- Pharmacology 16
Countries citing papers authored by Tim Cross
This map shows the geographic impact of Tim Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Cross more than expected).
Fields of papers citing papers by Tim Cross
This network shows the impact of papers produced by Tim Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Cross. The network helps show where Tim Cross may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tim Cross, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 1 | |
| 4 | 2021 | 16 | |
| 5 | 2021 | 40 | |
| 6 | 2021 | 2 | |
| 7 | 2019 | 50 | |
| 8 | 2019 | 16 | |
| 9 | 2018 | 40 | |
| 10 | 2018 | 1 | |
| 11 | 2018 | 1 | |
| 12 | 2017 | 1 | |
| 13 | 2016 | 2 | |
| 14 | 2016 | 1 | |
| 15 | 2014 | 20 | |
| 16 | 2014 | 1 | |
| 17 | 2014 | 32 | |
| 18 | 2014 | 1 | |
| 19 | 2010 | 30 | |
| 20 | 2007 | 10 |
About Tim Cross
Tim Cross is a scholar working on Hepatology, Epidemiology and Surgery, having authored 20 papers that have together received 270 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (11 papers), Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease and Transplantation (5 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Liver Diseases and Immunity (2 papers), Clinical practice guidelines implementation (1 paper), COVID-19 and healthcare impacts (1 paper) and Cardiac, Anesthesia and Surgical Outcomes (1 paper). The work is most often cited by research in Hepatology (154 citations), Epidemiology (137 citations) and Surgery (112 citations). Tim Cross has collaborated with scholars based in United Kingdom and India. Frequent co-authors include Dinesh Jothimani, Mark Ellul, Matthew Cramp, Ian Rowe, Anya Burton, R. Driver, Daniel H. Palmer, U. Warshow, Aileen Marshall and Paul Erasmus. Their work appears in journals such as British Journal of Cancer, European Journal of Surgical Oncology, BMJ Open, Journal of Hepatology and Gut.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.